EUVIMEDEUVIMED entdecken
Crossref

Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management

Akter Sraboni, Farhana Khandaker Mursheda, Mannan Kazi Abdul

Public Healthcare and Ancient Science · 2026

DOI: 10.64907/xkmf.v6.i1.phas.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Healthcare and Ancient Science, 2026. Verfasst von Akter Sraboni und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has reached unprecedented levels, posing significant challenges to health systems, particularly in low- and middle-income countries. While traditional lifestyle interventions-dietary modification, physical activity, and behavioural change-remain foundational in prevention and management strategies, their long-term effectiveness has been limited by biological, social, and structural constraints. In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin-based therapies have emerged as transformative pharmacological tools, demonstrating substantial efficacy in glycemic control, weight reduction, and cardiometabolic risk mitigation. This public health review critically examines the integration of modern GLP-1–based therapies with traditional lifestyle interventions, emphasising synergy rather than substitution. Using a qualitative methodology grounded in narrative synthesis and policy analysis, the study draws upon clinical trials, public health guidelines, and sociobehavioral research to explore effectiveness, equity, ethical considerations, and implementation challenges. A socioecological and chronic care theoretical framework is employed to contextualise obesity and diabetes as complex, multifactorial conditions requiring sustained, system-level responses. The review argues that GLP-1 therapies, when embedded within comprehensive lifestyle and public health strategies, offer a more realistic and equitable pathway for long-term disease management. However, issues of access, affordability, cultural adaptation, and health system capacity remain critical barriers. The article concludes with policy-oriented recommendations for integrating pharmacotherapy and lifestyle interventions in a manner that strengthens public health outcomes while minimising inequities. Keywords: GLP-1 receptor agonists, obesity, type 2 diabetes, lifestyle intervention, public health, qualitative review

Zitieren

APA

Sraboni, A., Mursheda, F. K., & Abdul, M. K. (2026). Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management. Public Healthcare and Ancient Science. https://doi.org/10.64907/xkmf.v6.i1.phas.1

Vancouver

Sraboni A, Mursheda FK, Abdul MK. Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management. Public Healthcare and Ancient Science. 2026. doi:10.64907/xkmf.v6.i1.phas.1

BibTeX
@article{Sraboni2026,
  author = {Sraboni, Akter and Mursheda, Farhana Khandaker and Abdul, Mannan Kazi},
  title = {Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management},
  journal = {Public Healthcare and Ancient Science},
  year = {2026},
  doi = {10.64907/xkmf.v6.i1.phas.1}
}
Kostenlos starten →